![]() | |
Clinical data | |
---|---|
Other names | 4,5,6,7-Tetrahydroisoxazolo[4,5-c]pyridin-3(2H)-one |
Drug class | GABA reuptake inhibitor |
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChEMBL | |
Chemical and physical data | |
Formula | C6H8N2O2 |
Molar mass | 140.142 g·mol−1 |
3D model (JSmol) | |
| |
|
THPO, also known as 4,5,6,7-tetrahydroisoxazolo[4,5-c]pyridin-3(2H)-one, is a relatively weak GABA reuptake inhibitor with some glial selectivity. [1] [2] It is a synthetic and conformationally restrained analogue of the GABAA receptor agonist and weak GABA reuptake inhibitor muscimol (found in Amanita muscaria ). [1] Unlike muscimol however, THPO is a selective GABA reuptake inhibitor and lacks GABAA receptor affinity. [3] [2] The drug penetrates into the brain in newborn mice, but shows only very limited central penetration in animals with fully developed brains. [2] Other structurally related selective GABA reuptake inhibitors include guvacine, nipecotic acid, and tiagabine. [1] [2]